RNAC
Cartesian Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Carsten Brunn
IPO Date
2016-06-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Cartesian Therapeutics, Inc.
CEO
Carsten Brunn
IPO Date
2016-06-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 22,740.03 |
| $0.00 |
| 6 Apr 2026 | Kalayoglu Murat | 10 percent owner | M-Exempt | Acquired | 758,001 | $0.00 |
| 6 Apr 2026 | Kalayoglu Murat | 10 percent owner | M-Exempt | Disposed | 22,740.03 | $0.00 |
| 13 Mar 2026 | Singer Michael | director | G-Gift | Disposed | 6,555 | $0.00 |
| 8 Jan 2026 | Brunn Carsten | director, officer: President and CEO | S-Sale | Disposed | 23,766 | $6.82 |
| 8 Jan 2026 | Miljkovic Milos | Chief Medical Officer | S-Sale | Disposed | 3,573 | $6.82 |
| 8 Jan 2026 | Davis Blaine | Chief Financial Officer | S-Sale | Disposed | 10,591 | $6.82 |
| 6 Jan 2026 | DeSilva Nishan M | director | A-Award | Acquired | 2,600 | $0.00 |
| 6 Jan 2026 | DeSilva Nishan M | director | A-Award | Acquired | 7,800 | $6.76 |